Medios AG (MEDOF)
PNK: MEDOF
· Real-Time Price · USD
50.00
0.00 (0.00%)
At close: Apr 30, 2025, 8:00 PM
Company Description
Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany.
It operates through Pharmaceutical Supply and Patient-Specific Therapies segments.
The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases.
The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets.
The company was founded in 2016 and is based in Berlin, Germany.
Medios AG
| Country | DE |
| IPO Date | Nov 10, 2021 |
| Industry | Medical - Distribution |
| Sector | Healthcare |
| Employees | 472 |
| CEO | Matthias Gaertner |
Contact Details
Address: Heidestrasse 9 Berlin, DE | |
| Website | https://www.medios.ag |
Stock Details
| Ticker Symbol | MEDOF |
| Exchange | PNK |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | DE000A1MMCC8 |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Matthias Gaertner | Chief Executive Officer & Chairman of the Executive Board |
| Falk Neukirch | Chief Financial Officer & Member of Executive Board |
| Mi-Young Miehler | Chief Operating Officer & Member of Executive Board |
| Christoph Prußeit | Chief Innovation Officer & Member of Executive Board |
| Claudia Nickolaus | Head of Investor & Public Relations |
| Constantijn van Rietschoten | Chief of International Markets & Member of Executive Board |
| Dr. Yann Samson | Chairman of Supervisory Board & Sustainability Officer |